Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesExchange Rate EffectFree Cash FlowNet Cash FlowNet Income
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Gains from Sales and Divestitures: 2019-2022

  • Burning Rock Biotech's Gains from Sales and Divestitures was N/A to $18,000 in Q2 2022 from the same period last year, while for Jun 2022 it was $18,000, marking a year-over-year change of. This contributed to the annual value of $17,984 for FY2021, which is N/A change from last year.
  • According to the latest figures from Q2 2022, Burning Rock Biotech's Gains from Sales and Divestitures is $18,000, which was down 0.79% from $18,144 recorded in Q4 2021.
  • Over the past 5 years, Burning Rock Biotech's Gains from Sales and Divestitures peaked at $18,144 during Q4 2021, and registered a low of $4,398 during Q4 2019.
  • In the last 2 years, Burning Rock Biotech's Gains from Sales and Divestitures had a median value of $18,072 in 2022 and averaged $18,072.